Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Certain diets may help with hair growth in people with different types of hair loss.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Educating dermatologists and screening for related conditions are crucial for treating folliculitis decalvans effectively.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Proper management and preventative measures can reduce serious adverse events from deoxycholic acid injections for fat reduction.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Ruxolitinib can cause a delayed skin reaction on the nose.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Exosome treatment from stem cells improved hair regrowth and reduced scalp issues in a woman with lichen planopilaris.

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

A woman's complete hair loss condition improved after recovering from COVID-19.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.